First-Line Switch to B/F/TAF for Treatment of HIV in Older Adults ≥60 Years in Kenya (the B/F/TAF-Elderly Study) - Top-Institutions - MDSpire

First-Line Switch to B/F/TAF for Treatment of HIV in Older Adults ≥60 Years in Kenya (the B/F/TAF-Elderly Study)

  • By

  • Loice Achieng Ombajo

  • Jeremy Penner

  • Joseph Nkuranga

  • Victor Omodi

  • Edwin Otieno

  • Jared Ongechi Mecha

  • Simon Wahome

  • Florentius Ndinya

  • Rukia Aksam

  • Sanjay Bhagani

  • Rose Wafula

  • Anton Pozniak

  • Diana Nyakoe

  • On behalf of

  • the B/F/TAF-Elderly Study Group

  • Ruth Wanjohi

  • Arnold Onyango

  • Foram Bhogayata

  • Janet Oyoo

  • Susan Onywera

  • Martha Atandi

  • Agatha Theuri

  • Beryl Handa

  • Elizabeth Kamau

  • Susan Wanjiru

  • Eunice Karuoya

  • Amos Ongubo

  • Gerald Kiambi

  • Sheila Eshiwani Juliet

  • Lillian Gekonge

  • Florence Kinyanjui

  • Betty Chepchumba

  • Alex Morwabe

  • Kevin Wauna

  • Felix Hinga

  • November 20, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Center for AIDS Research
    University of California, San Francisco (UCSF) Center for AIDS Research

    San Francisco, CA

    Key Differentiators

    • HIV/AIDS research
    • Geriatric medicine
    • Infectious diseases

  • #2

    University of Cape Town, Desmond Tutu HIV Centre
    University of Cape Town, Desmond Tutu HIV Centre

    Cape Town, Western Cape

    Key Differentiators

    • HIV clinical trials
    • Infectious diseases
    • Public health in Africa

  • #3

    Johns Hopkins University School of Medicine, Division of Infectious Diseases
    Johns Hopkins University School of Medicine, Division of Infectious Diseases

    Baltimore, MD

    Key Differentiators

    • HIV/AIDS clinical research
    • Geriatrics
    • Nephrology

  • #4

    Kenya Medical Research Institute (KEMRI)
    Kenya Medical Research Institute (KEMRI)

    Nairobi, Nairobi County

    Key Differentiators

    • HIV clinical research
    • Public health
    • Infectious diseases

  • #5

    Massachusetts General Hospital, HIV Clinical Trials Unit
    Massachusetts General Hospital, HIV Clinical Trials Unit

    Boston, MA

    Key Differentiators

    • HIV clinical trials
    • Geriatrics
    • Bone metabolism

Original Source(s)

First-Line Switch to B/F/TAF for Treatment of HIV in Older Adults ≥60 Years in Kenya (the B/F/TAF-Elderly Study)

  • by Loice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga, Victor Omodi, Edwin Otieno, Jared Ongechi Mecha, Simon Wahome, Florentius Ndinya, Rukia Aksam, Sanjay Bhagani, Rose Wafula, Anton Pozniak, Diana Nyakoe, On behalf of, the B/F/TAF-Elderly Study Group, Ruth Wanjohi, Arnold Onyango, Foram Bhogayata, Janet Oyoo, Susan Onywera, Martha Atandi, Agatha Theuri, Beryl Handa, Elizabeth Kamau, Susan Wanjiru, Eunice Karuoya, Amos Ongubo, Gerald Kiambi, Sheila Eshiwani Juliet, Lillian Gekonge, Florence Kinyanjui, Betty Chepchumba, Alex Morwabe, Kevin Wauna, Felix Hinga

  • November 20, 2025

Related Content

Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12

Increasing Handgrip Strength to Combat Frailty in Human Immunodeficiency Virus: Linking Immune Exhaustion to a Bone Health Indicator

Cardiovascular diseases, prevention, and management of complications in older adults and frail patients treated for elective or post-traumatic hip orthopaedic interventions: a clinical consensus statement of the ESC Council for Cardiology Practice (CCP), the European Association of Preventive Cardiology (EAPC), the Association for Acute CardioVascular Care (ACVC), the Association of Cardiovascular Nursing & Allied Professions of the ESC (ACNAP), the ESC Working Group on Aorta and Peripheral Vascular Diseases (WG APVD), and the ESC Working Group on Thrombosis (WG T)